| Name | ASLAN003 |
|---|
| Description | ASLAN003 is an orally active and potent inhibitor of DHODH (Human Dihydroorotate Dehydrogenase) which has the potential to be a first-in-class candidate in AML (Acute Myelogenous Leukemia). ASLAN003 has antitumor activity[1]. |
|---|---|
| Related Catalog | |
| Target |
DHODH[1] |
| References |
| Molecular Formula | C19H14F2N2O3 |
|---|---|
| Molecular Weight | 356.32 |